“The outlook revision reflects our view of EJGH’s heightened operating losses in fiscal years 2014 and 2015 along with some weakening of unrestricted reserves,” said S&P analyst Suzie Desai.
More articles on healthcare finance:
Prescription drug costs around the globe
2 lawyers weigh in on OIG report putting spotlight on provider-based billing
Cerner adds new revenue cycle leadership: 5 questions with Cerner president, new SVP of RCM
Next Up in Financial Management
-
Healthcare CEOs are prioritizing workforce and AI as they plan for rising demand, with 83% naming AI a top investment…
-
Illinois officials have declined to provide additional financial aid to Reno, Nev.-based American Healthcare Systems’ Waukegan, Ill.-based Vista Medical Center…
-
Rochester, Minn.-based Mayo Clinic recorded operating income of $414 million (7% operating margin) in the third quarter of 2026, down…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.